MedTrace Logo

Biomarkers in Pediatric Inflammatory Rheumatic Diseases

NCT07356804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2026-01-21

No results posted yet for this study

Summary

A prospective study is proposed to serially determine new biomarkers: Calprotectin and Serum Amyloid Protein, alongside 'conventional' biomarkers: CRP and ESR, to help evaluate their utility in routine clinical practice

Conditions

  • Juvenile Idiopathic Arthritis
  • Flare Up, Symptom

Interventions

DIAGNOSTIC_TEST

Calprotectine

Determination of calprotectin and amyloid protein in the serum of patients

Sponsors & Collaborators

  • Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    lead OTHER

Principal Investigators

  • Berta Magallares · Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau - IIB Sant Pau

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-05
Primary Completion
2019-12-30
Completion
2020-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07356804 on ClinicalTrials.gov